跳至主要内容
临床试验/IRCT20220112053701N1
IRCT20220112053701N1招募中2 期

Evaluation of the effect of subcutaneous adalimumab on the prognosis of patients with COVID-19: a pilot study in patients admitted to Afzalipour hospital in Kerman

Kerman University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60 years 至 70 years(—)
性别
All

入选标准

  • Severe COVID-19 (respiratory rate more than 30 per minute or oxygen saturation less than 90% or more than 50% lung parenchyma involvement on the patient's CT scan)
  • Patient's consent
  • Age: 60_70 years old

排除标准

  • Fever (body temp above 40°C)
  • Any active bacterial or fungal infection
  • Positive blood and urine culture
  • History of chronic obstructive pulmonary disease
  • History of tuberculosis
  • Heart failure
  • Infectious skin wounds
  • History of multiple sclerosis
  • Very severe/critical stage of the disease (shock, encephalopathy, myocardial lesion, coagulation, and renal impairment)
  • abnormal liver tests in the form of liver enzymes more than 2 times normal
  • GFR less than or equal to 30

研究者

相似试验

进行中(未招募)
不适用
Clinical phase I/IIA study of subcutaneous administration of Ofatumumab in Rheumatoid Arthritis patients on stable dose Methotrexate. Ensayo clínico fase I/IIA de administración subcutánea de ofatumumab en pacientes con artritis reumatoide tratados con dosis estables de metotrexato.Rheumatoid ArthritisArtritis ReumatoideMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritis
EUCTR2008-002046-27-ESGlaxoSmithKline S.A.70
进行中(未招募)
不适用
Clinical phase I/IIA study of subcutaneous administration of Ofatumumab in Rheumatoid Arthritis patients on stable dose MethotrexateRheumatoid Arthritis
EUCTR2008-002046-27-DEGlaxoSmithKline Research & Development Ltd70
进行中(未招募)
不适用
Clinical phase I/IIA study of subcutaneous administration of Ofatumumab in Rheumatoid Arthritis patients on stable dose MethotrexateRheumatoid Arthritis
EUCTR2008-002046-27-BEGlaxoSmithKline Research & Development Ltd35
进行中(未招募)
不适用
Evaluation of the efficacy and safety of adalimumab (Humira) s.c. injections eow. in patients with adhesive capsulitis (frozen shoulder). - The TEST Trial
EUCTR2006-005426-23-DKPierre Schydlowsky
已完成
不适用
The effect of subcutaneous and intracutaneous injection of distilled sterilized water and normal saline on the severity of childbirth paiStudy of the effect of injection distilled sterilized water and normal saline on the severity of labor pain.Pain, unspecified
IRCT20180128038535N1Jahrom University of Medical Sciences164
Evaluation of the effect of subcutaneous adalimumab... | 临床试验